Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-22-069009

SVP, Chief Financial Officer gave up 35,284 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coiante Scott M SVP, Chief Financial Officer 2022-06-03 Shares withheld for taxes −35,284 $0.81 $28,404 84,265 D
Loading xslF345X03/tm2217848-3_4seq1.xml…